Cargando…

Discovery proteomics defines androgen-regulated glycoprotein networks in prostate cancer cells, as well as putative biomarkers of prostatic diseases

Supraphysiologic androgen (SPA) inhibits cell proliferation in prostate cancer (PCa) cells by transcriptional repression of DNA replication and cell-cycle genes. In this study, quantitative glycoprotein profiling identified androgen-regulated glycoprotein networks associated with SPA-mediated inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsiao, Jordy J., Smits, Melinda M., Ng, Brandon H., Lee, Jinhee, Wright, Michael E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592995/ https://www.ncbi.nlm.nih.gov/pubmed/34782677 http://dx.doi.org/10.1038/s41598-021-01554-2

Ejemplares similares

Discovery Proteomics Identifies a Molecular Link between the Coatomer Protein Complex I and Androgen Receptor-dependent Transcription
por: Hsiao, Jordy J., et al.
Publicado: (2016)

Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility
por: Hsiao, Jordy J, et al.
Publicado: (2015)

Androgen receptor: structure, role in prostate cancer and drug discovery
por: Tan, MH Eileen, et al.
Publicado: (2015)

P-Glycoprotein and Androgen Receptor Expression Reveals Independence of Canine Prostate Cancer from Androgen Hormone Stimulation
por: Cavalca, Alexandre Matheus Baesso, et al.
Publicado: (2022)

Rapid Androgen-Responsive Proteome Is Involved in Prostate Cancer Progression
por: Kim, Jong-Kwang, et al.
Publicado: (2021)

Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer
por: O'Hurley, Gillian, et al.
Publicado: (2015)

Discovery of prostate specific antigen pattern to predict castration resistant prostate cancer of androgen deprivation therapy
por: Kim, Yejin, et al.
Publicado: (2016)

Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer
por: Obinata, Daisuke, et al.
Publicado: (2020)

Androgens and prostate disease
por: Cooper, Lori A, et al.
Publicado: (2014)

Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery
por: Tanase, Cristiana Pistol, et al.
Publicado: (2017)

Proteomic Analysis of Exosomes for Discovery of Protein Biomarkers for Prostate and Bladder Cancer
por: Wang, Yi-Ting, et al.
Publicado: (2020)

GRK2 Enforces Androgen Receptor-Dependence in the Prostate and Prostate Tumors
por: Adler, Adam J., et al.
Publicado: (2020)

Polyisoprenylated methylated protein methyl esterase as a putative drug target for androgen-insensitive prostate cancer
por: Poku, Rosemary A, et al.
Publicado: (2014)

Androgen resistance in prostate cancer
por: Waxman, J, et al.
Publicado: (2008)

Androgens, aging, and prostate health
por: Welén, Karin, et al.
Publicado: (2022)

Single-cell proteomics defines the cellular heterogeneity of localized prostate cancer
por: De Vargas Roditi, Laura, et al.
Publicado: (2022)

Antiandrogens Act as Selective Androgen Receptor Modulators at the Proteome Level in Prostate Cancer Cells
por: Brooke, Greg N., et al.
Publicado: (2015)

Chromatin-directed proteomics-identified network of endogenous androgen receptor in prostate cancer cells
por: Launonen, Kaisa-Mari, et al.
Publicado: (2021)

Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer
por: Kohli, Manish, et al.
Publicado: (2012)

Putative Prostate Cancer Risk SNP in an Androgen Receptor‐Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in Androgen Receptor Target Sites
por: Bu, Huajie, et al.
Publicado: (2015)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Hormones and prostate carcinogenesis: Androgens and estrogens
por: Bosland, Maarten C., et al.
Publicado: (2011)

Mechanisms of Androgen-Independent Prostate Cancer
por: Saraon, Punit, et al.
Publicado: (2014)

Plasma Androgen Receptor in Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

Effects of Androgen Receptor and Androgen on Gene Expression in Prostate Stromal Fibroblasts and Paracrine Signaling to Prostate Cancer Cells
por: Tanner, Matthew J., et al.
Publicado: (2011)

Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells
por: LIU, TIANCHENG, et al.
Publicado: (2012)

The Discovery of Putative Urine Markers for the Specific Detection of Prostate Tumor by Integrative Mining of Public Genomic Profiles
por: Chen, Min, et al.
Publicado: (2011)

Molecular Signatures of Membrane Protein Complexes Underlying Muscular Dystrophy
por: Turk, Rolf, et al.
Publicado: (2016)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
por: Eisermann, Kurtis, et al.
Publicado: (2017)

Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer
por: Culig, Zoran
Publicado: (2021)

Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
por: Zhang, Haozhe, et al.
Publicado: (2022)

Regulation of Prostate Androgens by Megalin and 25-hydroxyvitamin D Status: Mechanism for High Prostate Androgens in African American Men
por: Garcia, Jason, et al.
Publicado: (2023)

Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy
por: Wilding, Sarah, et al.
Publicado: (2019)

Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies
por: Moilanen, Anu-Maarit, et al.
Publicado: (2015)

Biomarkers of Response to Neoadjuvant Androgen Deprivation in Localised Prostate Cancer
por: Pechlivanis, Maree, et al.
Publicado: (2021)

Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy?
por: Peinetti, Nahuel, et al.
Publicado: (2022)

Androgen receptor isoforms expression in benign prostatic hyperplasia and primary prostate cancer
por: Hillebrand, Ana Caroline, et al.
Publicado: (2018)

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
por: Vickman, Renee E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i75oc03b78l5kco8kt3bfcc8qj